1. Home
  2. CUE vs ORMP Comparison

CUE vs ORMP Comparison

Compare CUE & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUE
  • ORMP
  • Stock Information
  • Founded
  • CUE 2014
  • ORMP 2002
  • Country
  • CUE United States
  • ORMP United States
  • Employees
  • CUE N/A
  • ORMP N/A
  • Industry
  • CUE Biotechnology: Pharmaceutical Preparations
  • ORMP Biotechnology: Pharmaceutical Preparations
  • Sector
  • CUE Health Care
  • ORMP Health Care
  • Exchange
  • CUE Nasdaq
  • ORMP Nasdaq
  • Market Cap
  • CUE 91.9M
  • ORMP 90.7M
  • IPO Year
  • CUE 2018
  • ORMP N/A
  • Fundamental
  • Price
  • CUE $1.26
  • ORMP $2.17
  • Analyst Decision
  • CUE Strong Buy
  • ORMP Hold
  • Analyst Count
  • CUE 5
  • ORMP 1
  • Target Price
  • CUE $5.00
  • ORMP N/A
  • AVG Volume (30 Days)
  • CUE 276.0K
  • ORMP 113.6K
  • Earning Date
  • CUE 03-10-2025
  • ORMP 03-05-2025
  • Dividend Yield
  • CUE N/A
  • ORMP N/A
  • EPS Growth
  • CUE N/A
  • ORMP N/A
  • EPS
  • CUE N/A
  • ORMP 0.11
  • Revenue
  • CUE $9,532,000.00
  • ORMP N/A
  • Revenue This Year
  • CUE $73.11
  • ORMP N/A
  • Revenue Next Year
  • CUE $11.02
  • ORMP N/A
  • P/E Ratio
  • CUE N/A
  • ORMP $20.19
  • Revenue Growth
  • CUE 149.53
  • ORMP N/A
  • 52 Week Low
  • CUE $0.45
  • ORMP $2.00
  • 52 Week High
  • CUE $2.58
  • ORMP $3.67
  • Technical
  • Relative Strength Index (RSI)
  • CUE 49.50
  • ORMP 36.05
  • Support Level
  • CUE $1.27
  • ORMP $2.12
  • Resistance Level
  • CUE $1.50
  • ORMP $2.27
  • Average True Range (ATR)
  • CUE 0.12
  • ORMP 0.07
  • MACD
  • CUE -0.01
  • ORMP -0.01
  • Stochastic Oscillator
  • CUE 53.73
  • ORMP 22.73

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

Share on Social Networks: